This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Identify smart fund options for retirement diversification, focusing on balance, risk management, and practical allocation ideas for real-world use.
24,189 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Nvidia is a cornerstone of the AI era, and its upcoming earnings can move markets. This guide breaks down what to con...
XRP has shed roughly 44% over the past year, prompting renewed debate about a rebound. Analysts point to regulatory c...
Can a modest $1,000 investment in Micron Technology realistically grow to $10,000? This guide breaks down the memory-...
Anthropic's Mythos stirred AI headlines and sent one cybersecurity stock soaring. This article breaks down whether PA...
Intel has powered a 492% surge in a year, but a wave of insider selling has traders weighing how durable the rebound ...
A new study finds Republican lawmakers are increasingly tilting their portfolios toward Bitcoin and related crypto as...
MoneyHero fans will be watching the 2025 earnings with a keen eye for growth, margins, and the companys path to profi...
As the Pentagon bets big on affordable, domestically produced drones, investors wonder if Red Cat Holdings can ride t...
SpaceX's plan to go public is one of a kind. This article breaks down what it could mean for investors, from the loft...
South Korea’s KOSPI dropped sharply after circuit-breaker rules kicked in, fueling anxiety about a potential spillove...
On a June trading day, Payoneer Global surged on takeover chatter, highlighting how M&A rumors can move fintech names...